| NBK Capital provides growth capital to Dem Pharmaceutical |
| Wednesday, 04 January 2012 04:41 | |||
|
Kuwait: NBK Capital announced that it has completed an investment in Dem Pharmaceutical, a niche pharmaceutical company specializing in biological drugs that treat life-threatening conditions. The investment was made through the Firm's pioneering NBK Capital Mezzanine Fund, the MENA region's first fund dedicated to providing alternative financing solutions to growth companies. [AMEInfo.com]
Read more: NBK Capital provides growth capital to Dem Pharmaceutical
|